ALX ONCOLOGY HOLDINGS INC
For the period ended Dec 31, 2025. Filed Mar 9, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 9, 2026
ALXO$1.11-13.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Comprehensive Loss
(in thousands)
| Year Ended | |||
|---|---|---|---|
| December 31, | |||
| 2025 | 2024 | 2023 | |
| Net loss | $(101,695) | $(134,850) | $(160,805) |
| Other comprehensive gain (loss), net of tax: | |||
| Unrealized gain (loss) on available-for-sale investments | (247) | 19 | 1,101 |
| Total comprehensive loss | $(101,942) | $(134,831) | $(159,704) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.